Capital Performance Advisors LLP Iradimed Corp Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Iradimed Corp stock. As of the latest transaction made, Capital Performance Advisors LLP holds 25 shares of IRMD stock, worth $1,207. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$1,207% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IRMD
# of Institutions
143Shares Held
6.83MCall Options Held
6.9KPut Options Held
100-
Nine Ten Capital Management LLC Evanston, IL878KShares$42.4 Million14.85% of portfolio
-
Black Rock Inc. New York, NY818KShares$39.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny560KShares$27.1 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA469KShares$22.7 Million0.0% of portfolio
-
Copeland Capital Management, LLC422KShares$20.4 Million0.38% of portfolio
About IRADIMED CORP
- Ticker IRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 12,565,100
- Market Cap $607M
- Description
- IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...